Published 4 days ago • loading... • Updated 4 days ago

Top Biotech Undercuts Breakout On Bad Medicare News

Summary by Investor's Business Daily

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

1 Articles

All

Left

Center

Right

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

4 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated4 days agoBias Distribution

100% Right

100% Right

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Investor's Business Daily broke the news in 4 days ago on Tuesday, May 13, 2025.

Sources are mostly out of (0)